- Home
- SLQT vs AVXL Comparison
SLQT vs AVXL Comparison
Compare SLQT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- AVXL
- Stock Information
- Founded
- SLQT 1999
- AVXL 2004
- Country
- SLQT United States
- AVXL United States
- Employees
- SLQT N/A
- AVXL N/A
- Industry
- SLQT Specialty Insurers
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLQT Finance
- AVXL Health Care
- Exchange
- SLQT Nasdaq
- AVXL Nasdaq
- Market Cap
- SLQT 408.2M
- AVXL 484.2M
- IPO Year
- SLQT 2020
- AVXL N/A
- Fundamental
- Price
- SLQT $2.45
- AVXL $7.45
- Analyst Decision
- SLQT Hold
- AVXL Strong Buy
- Analyst Count
- SLQT 1
- AVXL 2
- Target Price
- SLQT $4.00
- AVXL $43.00
- AVG Volume (30 Days)
- SLQT 1.2M
- AVXL 1.6M
- Earning Date
- SLQT 11-04-2024
- AVXL 11-25-2024
- Dividend Yield
- SLQT N/A
- AVXL N/A
- EPS Growth
- SLQT N/A
- AVXL N/A
- EPS
- SLQT N/A
- AVXL N/A
- Revenue
- SLQT $1,381,309,000.00
- AVXL N/A
- Revenue This Year
- SLQT $11.29
- AVXL N/A
- Revenue Next Year
- SLQT $14.41
- AVXL N/A
- P/E Ratio
- SLQT N/A
- AVXL N/A
- Revenue Growth
- SLQT 28.72
- AVXL N/A
- 52 Week Low
- SLQT $1.03
- AVXL $3.25
- 52 Week High
- SLQT $4.46
- AVXL $10.45
- Technical
- Relative Strength Index (RSI)
- SLQT 59.54
- AVXL 54.68
- Support Level
- SLQT $1.92
- AVXL $7.55
- Resistance Level
- SLQT $2.65
- AVXL $10.45
- Average True Range (ATR)
- SLQT 0.16
- AVXL 0.84
- MACD
- SLQT 0.06
- AVXL 0.08
- Stochastic Oscillator
- SLQT 72.60
- AVXL 37.77
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.